Adaptive (ADPT) Reports Q1 2026 Earnings with Strong Revenue Growth
Adaptive (ADPT) reported Q1 2026 earnings with total revenue of $70.9 million, a 45% year-over-year increase, driven largely by its MRD business. The company highlighted strong growth in clinical and pharma segments, improved operational efficiencies, and increased physician engagement.
Tickers: $ADPT
Topics: ASP clinical testing gross margin MRD business pharma segment revenue